BridgeBio Advances Therapy for Limb-Girdle Muscular Dystrophy that Started with Two Patient Families

RARECast - Ein Podcast von RARECast - Donnerstags

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

Kategorien:

Wirtschaft

Doug Sproule, chief medical officer of ML Bio Solutions, discusses limb girdle muscular dystrophy type 2i, the company’s experimental therapy to treat the condition, and the power of rare disease patient families to shape drug development.

Visit the podcast's native language site